VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,781,657 | -16.6% | 66,208 | -6.7% | 0.18% | -14.1% |
Q2 2023 | $2,136,635 | -32.5% | 70,961 | -27.5% | 0.21% | -35.3% |
Q1 2023 | $3,166,288 | -6.2% | 97,876 | -16.9% | 0.33% | -8.9% |
Q4 2022 | $3,374,313 | -43.8% | 117,736 | -52.7% | 0.36% | -47.6% |
Q3 2022 | $6,004,000 | -37.6% | 248,940 | -29.2% | 0.69% | -30.0% |
Q2 2022 | $9,621,000 | -29.3% | 351,373 | -1.0% | 0.98% | -17.4% |
Q1 2022 | $13,605,000 | +34.5% | 354,768 | +12.4% | 1.19% | +39.0% |
Q4 2021 | $10,114,000 | -6.9% | 315,752 | -14.3% | 0.86% | -16.1% |
Q3 2021 | $10,863,000 | -5.3% | 368,586 | +9.1% | 1.02% | -7.8% |
Q2 2021 | $11,475,000 | +25.2% | 337,702 | +19.8% | 1.11% | +18.4% |
Q1 2021 | $9,164,000 | +39.3% | 281,982 | +54.4% | 0.94% | +37.0% |
Q4 2020 | $6,578,000 | +30.1% | 182,604 | +41.4% | 0.68% | +16.0% |
Q3 2020 | $5,056,000 | +54.9% | 129,096 | +45.1% | 0.59% | +44.7% |
Q2 2020 | $3,264,000 | – | 88,982 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |